What's new

Human medicines European public assessment report (EPAR): Spexotras, trametinib, Date of authorisation: 05/01/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Spexotras, trametinib, Date of authorisation: 05/01/2024, Revision: 5, Status: Authorised

Feb 18, 2025 - 16:10
 0
Human medicines European public assessment report (EPAR): Spexotras, trametinib, Date of authorisation: 05/01/2024, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Spexotras, trametinib, Date of authorisation: 05/01/2024, Revision: 5, Status: Authorised
Read More

Tags:

Previous Article

JetBlue’s Triumphant Return: Capital One Revives U.S. Airline Transfer Partnership

Next Article

The next mental health changes in physician licensure

Related Posts

Human medicines European public assessment report (EPAR): Izelvay, avacincaptad pegol, Status: Application withdrawn

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – May 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 21 May 2025, 10:00 (CEST) to 21 May 2025, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025  0

Summary of opinion: Columvi, 27/02/2025 Positive

Summary of opinion: Columvi, 27/02/2025 Positive

Feb 28, 2025  0